Immuneering Corp
- Last sale
- Nov 12, 2026 · -3.43%
- Market cap
- $237.03M
- 64.76M shares
- Filings
- 326
FY 2023−100.0% FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+255.9% FY25 yoy
- $237.03M
- —
- —
- 1.4×
- -19.19%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $316,952 | reported | |
| FY 2021 | 2021-12-31 | $2,079,961 | reported | |
| FY 2020 | 2020-12-31 | $2,311,535 | reported |
Pharmaceutical preparations
Immuneering Corp is the 240th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MREOMereo BioPharma Group plc$500.0K—8,375.6%$243.3MLFCRLifecore Biomedical, Inc.———$242.6MEVMNEvommune, Inc.$13.0M85.7%529.8%$241.9MBCYCBicycle Therapeutics PLC$72.6M105.8%301.7%$241.1MVNDAVanda Pharmaceuticals Inc.$216.1M8.7%102.0%$238.9M
IMRXImmuneering Corp (this company)———$237.0M
CTNMContineum Therapeutics, Inc.———$226.4MZNTLZentalis Pharmaceuticals, Inc.$0.0100.0%—$225.5MGLSIGreenwich LifeSciences, Inc.———$222.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Immuneering Corp · CIK 1790340 · Engraved from SEC EDGAR